179 related articles for article (PubMed ID: 17496238)
1. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects.
Uribarri J; Stirban A; Sander D; Cai W; Negrean M; Buenting CE; Koschinsky T; Vlassara H
Diabetes Care; 2007 Oct; 30(10):2579-82. PubMed ID: 17496238
[TBL] [Abstract][Full Text] [Related]
2. Serum level of advanced glycation end-products (AGEs) is an independent determinant of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic general population.
Yamagishi S; Adachi H; Takeuchi M; Enomoto M; Furuki K; Matsui T; Nakamura K; Imaizumi T
Horm Metab Res; 2007 Nov; 39(11):845-8. PubMed ID: 17992643
[TBL] [Abstract][Full Text] [Related]
3. A novel advanced glycation index and its association with diabetes and microangiopathy.
Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
6. High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients.
Cai W; He JC; Zhu L; Peppa M; Lu C; Uribarri J; Vlassara H
Circulation; 2004 Jul; 110(3):285-91. PubMed ID: 15249511
[TBL] [Abstract][Full Text] [Related]
7. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
[TBL] [Abstract][Full Text] [Related]
9. The acute effect of various glycemic index dietary carbohydrates on endothelial function in nondiabetic overweight and obese subjects.
Lavi T; Karasik A; Koren-Morag N; Kanety H; Feinberg MS; Shechter M
J Am Coll Cardiol; 2009 Jun; 53(24):2283-7. PubMed ID: 19520253
[TBL] [Abstract][Full Text] [Related]
10. Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans.
Enomoto M; Adachi H; Yamagishi S; Takeuchi M; Furuki K; Hino A; Hiratsuka A; Takajo Y; Imaizumi T
Metabolism; 2006 Jul; 55(7):912-7. PubMed ID: 16784963
[TBL] [Abstract][Full Text] [Related]
11. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
12. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.
Xiang GD; Sun HL; Zhao LS; Hou J; Yue L; Xu L
Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
[TBL] [Abstract][Full Text] [Related]
14. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
Nishizawa Y; Koyama H
J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
[TBL] [Abstract][Full Text] [Related]
15. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome.
Scuteri A; Tesauro M; Rizza S; Iantorno M; Federici M; Lauro D; Campia U; Turriziani M; Fusco A; Cocciolillo G; Lauro R
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):349-56. PubMed ID: 17935958
[TBL] [Abstract][Full Text] [Related]
16. Products of advanced glycation in patients with type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Pokupec R; Turk N; Stavljenić-Rukavina A
Ann Clin Biochem; 2003 Sep; 40(Pt 5):552-9. PubMed ID: 14503994
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
18. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial.
Balzer J; Rassaf T; Heiss C; Kleinbongard P; Lauer T; Merx M; Heussen N; Gross HB; Keen CL; Schroeter H; Kelm M
J Am Coll Cardiol; 2008 Jun; 51(22):2141-9. PubMed ID: 18510961
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
Yamagishi S; Nakamura K; Matsui T; Inoue H; Takeuchi M
Med Hypotheses; 2007; 69(3):666-8. PubMed ID: 17331665
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.
Aversa A; Vitale C; Volterrani M; Fabbri A; Spera G; Fini M; Rosano GM
Diabet Med; 2008 Jan; 25(1):37-44. PubMed ID: 18199130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
